Differential Expression and miRNA–Gene Interactions in Early and Late Mild Cognitive Impairment
Mild cognitive impairment (MCI) and Alzheimer’s Disease (AD) are complex diseases with their molecular architecture not elucidated. <i>APOE</i>, Amyloid Beta Precursor Protein (<i>APP</i>), and Presenilin-1 (<i>PSEN1</i>) are well-known genes associated with both...
Main Authors: | Leonardo Miranda Brito, Ândrea Ribeiro-dos-Santos, Amanda Ferreira Vidal, Gilderlanio Santana de Araújo |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-08-01
|
Series: | Biology |
Subjects: | |
Online Access: | https://www.mdpi.com/2079-7737/9/9/251 |
Similar Items
-
Identification and validation of endogenous control miRNAs in plasma samples for normalization of qPCR data for Alzheimer’s disease
by: F. Dakterzada, et al.
Published: (2020-12-01) -
Exosomal miRNAs as Potential Diagnostic Biomarkers in Alzheimer’s Disease
by: Ida Manna, et al.
Published: (2020-09-01) -
Dysregulation of miRNA in Leukemia: Exploiting miRNA Expression Profiles as Biomarkers
by: Luisa Anelli, et al.
Published: (2021-07-01) -
Altered microRNAs related to synaptic function as potential plasma biomarkers for Alzheimer’s disease
by: Dolores Siedlecki-Wullich, et al.
Published: (2019-05-01) -
Clinical Translatability of “Identified” Circulating miRNAs for Diagnosing Breast Cancer: Overview and Update
by: Anna Maria Grimaldi, et al.
Published: (2019-06-01)